Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

v3.7.0.1
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2017
Notes to Financial Statements  
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

MedoveX Corp. (the “Company”) was incorporated in Nevada on July 30, 2013 as SpineZ Corp. (“SpineZ”) and changed its name to MedoveX Corp. on March 20, 2014. MedoveX is the parent company of Debride Inc. (“Debride”), which was incorporated under the laws of the State of Florida on October 1, 2012. The Company is in the business of designing and marketing proprietary medical devices for commercial use in the United States and Europe. The Company is currently seeking approval from the FDA and CE for the DenerveX System.